Kaidi Kang

Kaidi Kang

Auto-generated profile, based on publicly available information

Kaidi Kang

Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2024 in Nature
Verified
Journal Article
Open access
PDF file
KKKaidi Kang
Kaidi Kang
JSJakob Seidlitz
Jakob Seidlitz
RBRichard Bethlehem
Richard Bethlehem
JXJiangmei Xiong
Jiangmei Xiong
MJMegan T. Jones
Megan T. Jones
SVSimon Vandekar
Simon Vandekar
Brain-wide association studies (BWAS) are a fundamental tool in discovering brain–behaviour associations1,2. Several recent studies have shown that thousands of study participants are required for good replicability of BWAS1–3. Here we performed analyses and meta-analyses of a robust effect size index using 63 longitudinal and cross-sectional MRI studies from the Lifespan Brain Chart Consortium4 (77,695 total scans) to demonstrate that optimizing study design is critical for increasing standardized effect sizes and replicability in BWAS. A meta-analysis of brain volume associations with age indicates that BWAS with larger variability of the covariate and longitudinal studies have larger reported standardized effect size. Analysing age effects on global and regional brain measures from the UK Biobank and the Alzheimer’s Disease Neuroimaging Initiative, we showed that modifying study design through sampling schemes improves standardized effect sizes and replicability. To ensure that our results are generalizable, we further evaluated the longitudinal sampling schemes on cognitive, psychopathology and demographic associations with structural and functional brain outcome measures in the Adolescent Brain and Cognitive Development dataset. We demonstrated that commonly used longitudinal models, which assume equal between-subject and within-subject changes can, counterintuitively, reduce standardized effect sizes and replicability. Explicitly modelling the between-subject and within-subject effects avoids conflating them and enables optimizing the standardized effect sizes for each separately. Together, these results provide guidance for study designs that improve the replicability of BWAS.

1 March 2023 in Psychometrika
Verified
Journal Article
Open access
PDF file
KKKaidi Kang
Kaidi Kang
MJMegan T. Jones
Megan T. Jones
KAKristan Armstrong
Kristan Armstrong
SASuzanne Avery
Suzanne Avery
MMMaureen McHugo
Maureen McHugo
SVSimon Vandekar
Simon Vandekar
Reporting effect size index estimates with their confidence intervals (CIs) can be an excellent way to simultaneously communicate the strength and precision of the observed evidence. We recently proposed a robust effect size index (RESI) that is advantageous over common indices because it’s widely applicable to different types of data. Here, we use statistical theory and simulations to develop and evaluate RESI estimators and confidence/credible intervals that rely on different covariance estimators. Our results show (1) counter to intuition, the randomness of covariates reduces coverage for Chi-squared and F CIs; (2) when the variance of the estimators is estimated, the non-central Chi-squared and F CIs using the parametric and robust RESI estimators fail to cover the true effect size at the nominal level. Using the robust estimator along with the proposed nonparametric bootstrap or Bayesian (credible) intervals provides valid inference for the RESI, even when model assumptions may be violated. This work forms a unified effect size reporting procedure, such that effect sizes with confidence/credible intervals can be easily reported in an analysis of variance (ANOVA) table format.

19 June 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
KKKaidi Kang
Kaidi Kang
PZPanpan Zhang
Panpan Zhang
LDLogan Dumitrescu
Logan Dumitrescu
SMShubhabrata Mukherjee
Shubhabrata Mukherjee
MLMichael L. Lee
Michael L. Lee
DLDandan Liu
Dandan Liu
INTRODUCTION: Accurately assessing the temporal order of cognitive decline across multiple domains is critical in Alzheimer's disease (AD). Existing literature presents controversial conclusions likely due to the use of a single cohort and different analytical strategies.METHODS: Harmonized composite cognitive measures in memory, language, and executive functions from 13 cohorts in the Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium (ADSP‐PHC) were used. A double anchoring events–based sigmoidal mixed model was developed using time to incident AD diagnosis as the time scale.RESULTS: In general, decline in memory occurred before decline in language, followed by decline in executive function. This temporal order generally persisted within each subgroup of apolipoprotein E ε4 carrier status, sex, and race/ethnicity.DISCUSSION: This study demonstrated the use of harmonized data across multiple cohorts to characterize the temporal order of cognitive decline along AD progression. Using time to incident AD diagnosis as the time scale can enhance research reproducibility and clinical practice.Highlights: Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium's harmonized composite cognitive measures from 13 cohort studies fitted with a novel double anchoring event‐based sigmoidal mixed model reveal the following temporal order of cognitive decline toward AD progression: memory, language, and executive function. If only investigated using individual cohort studies, the temporal order of cognitive decline would vary due to the underlying heterogeneities across studies. This temporal order generally persisted within each subgroup of apolipoprotein E ε4 carrier status, sex, and race/ethnicity.

30 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
KKKaidi Kang
Kaidi Kang
JSJakob Seidlitz
Jakob Seidlitz
RBRichard Bethlehem
Richard Bethlehem
JXJiangmei Xiong
Jiangmei Xiong
MJMegan T. Jones
Megan T. Jones
SVSimon Vandekar
Simon Vandekar
Brain-wide association studies (BWAS) are a fundamental tool in discovering brain-behavior associations. Several recent studies showed that thousands of study participants are required for good replicability of BWAS because the standardized effect sizes (ESs) are much smaller than the reported standardized ESs in smaller studies. Here, we perform analyses and meta-analyses of a robust effect size index using 63 longitudinal and cross-sectional magnetic resonance imaging studies from the Lifespan Brain Chart Consortium (77,695 total scans) to demonstrate that optimizing study design is critical for increasing standardized ESs and replicability in BWAS. A meta-analysis of brain volume associations with age indicates that BWAS with larger variability in covariate have larger reported standardized ES. In addition, the longitudinal studies we examined reported systematically larger standardized ES than cross-sectional studies. Analyzing age effects on global and regional brain measures from the United Kingdom Biobank and the Alzheimer’s Disease Neuroimaging Initiative, we show that modifying longitudinal study design through sampling schemes improves the standardized ESs and replicability. Sampling schemes that improve standardized ESs and replicability include increasing between-subject age variability in the sample and adding a single additional longitudinal measurement per subject. To ensure that our results are generalizable, we further evaluate these longitudinal sampling schemes on cognitive, psychopathology, and demographic associations with structural and functional brain outcome measures in the Adolescent Brain and Cognitive Development dataset. We demonstrate that commonly used longitudinal models can, counterintuitively, reduce standardized ESs and replicability. The benefit of conducting longitudinal studies depends on the strengths of the between-versus within-subject associations of the brain and non-brain measures. Explicitly modeling between-versus within-subject effects avoids averaging the effects and allows optimizing the standardized ESs for each separately. Together, these results provide guidance for study designs that improve the replicability of BWAS.

9 December 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
XZXinmeng Zhang
Xinmeng Zhang
KKKaidi Kang
Kaidi Kang
CYChao Yan
Chao Yan
YFYubo Feng
Yubo Feng
SVSimon Vandekar
Simon Vandekar
You ChenYou Chen
You Chen
Background: Bariatric surgery is an effective intervention for obesity, but comprehensive postoperative self-management is essential for optimal outcomes. While patient portals are generally seen as beneficial in engaging patients in health management, the link between their use and post–bariatric surgery weight loss remains unclear. Objective: This study aimed to investigate the association between patient portal engagement and postoperative BMI reduction among patients after bariatric surgery. Methods: This retrospective longitudinal study included patients who underwent Roux-en-Y gastric bypass or sleeve gastrectomy at Vanderbilt University Medical Center between January 2018 and March 2021. Patient portal engagement was measured during 4 stages: early (within 3 months after surgery), early midterm (3-6 months), late midterm (6-9 months), and late (9-12 months). Using generalized estimating equations, we estimated the associations between patients’ portal engagements at these stages and the percentage of BMI reduction (%BMIR) at 3, 6, and 12 months after surgery. Covariates included duration since surgery, patient’s age at the time of surgery, sex, race and ethnicity, type of bariatric surgery, severity of comorbid conditions, and socioeconomic disadvantage. Results: The study included 1415 patients, predominantly female (n=1145, 80.9%), with a racial composition of 76.9% (n=1088) White and 19.9% (n=282) Black. Overall, 805 (56.9%) patients underwent Roux-en-Y gastric bypass and 610 (43.1%) underwent sleeve gastrectomy. By 1 year after surgery, the median %BMIR was 31.5% (IQR 25.2%-36.8%), and the median number of active days on the patient portal was 54 (IQR 33-80). Early portal engagement was significantly associated with %BMIR at various postoperative times. Specifically, each additional 10 days of early portal engagement was associated with a 0.37% (95% CI –0.55% to –0.18%; P<.001) lower expected %BMIR at 3 months, a 1.11% (95% CI 0.82%-1.41%; P<.001) higher expected %BMIR at 6 months, and a 0.78% (95% CI 0.25%-1.31%; P=.004) higher expected %BMIR at 12 months. Furthermore, early midterm portal engagement was associated with a 0.36% (95% CI –0.69 to –0.03; P=.03) lower expected %BMIR at 6 months, but it was not significant at 12 months (P=.88). Late midterm and late portal engagement were not significantly associated with %BMIR at 12 months (P=.27 and P=.12, respectively). Furthermore, early engagement in various portal functions, such as messaging and accessing medical records, was significantly associated with a lower %BMIR at 3 months and a higher %BMIR at both 6 and 12 months (all P<.05). Conclusions: Higher patient portal engagement within 3 months after surgery—suggestive of stronger adherence to postoperative instructions and improved communication with care teams—is associated with less favorable weight loss immediately after surgery but enhanced postoperative weight loss outcomes at 6 and 12 months. However, the limitations of retrospective data-driven studies highlight the need for future intervention-based studies to validate these associations and establish causality.

28 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
KMK. Murtha
K. Murtha
LDL. Dorfschmidt
L. Dorfschmidt
RBRichard Bethlehem
Richard Bethlehem
KKK. Kang
K. Kang
SVS. Vandekar
S. Vandekar
JSJ. Seidlitz
J. Seidlitz
Large population cohorts are needed to perform brain-wide association studies (BWAS), with evidence that sampling from the tails of a distribution increases effect sizes and improves reproducibility. However, studies rarely compare how variability in sample sociodemographic characteristics relates to imaging or behavioral phenotypes within BWAS. To address this gap, we derived estimates for brain-behavior associations using multivariate regression models, comparing effect sizes for dimensional, tail-sampled, and propensity matched groups. Data were obtained from the Adolescent Brain Cognitive Development (ABCD) Study®. The independent variables were brain structural imaging phenotypes, with a range of biological and psychological outcomes as dependent variables. We found expected increases in the magnitude of effect sizes moving from full-sample dimensional models to tail-sampled group-based models. However, findings for the propensity-matched group models suggested a non-uniform impact on BWAS (i.e., both increased and decreased effect sizes). Results suggest that sampling from the tails of the distribution of measures of brain structure generally increases effect sizes across biological, clinical, and cognitive outcomes.